Revenue: The sum of all revenue fields included for a company's operating activities.
Novartis AG (NVS) had Revenue of $13.62B for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$13.62B |
$3.61B |
|
$3.23B |
|
$10.39B |
|
$8.96B |
|
$4.66B |
|
$-256.00M |
|
$4.41B |
|
$4.41B |
|
$3.61B |
|
$3.61B |
|
$3.61B |
|
$3.61B |
|
$4.66B |
|
$5.86B |
|
1.97B |
|
1.98B |
|
$1.83 |
|
$1.82 |
|
| Balance Sheet Financials | |
$25.11B |
|
$9.68B |
|
$74.83B |
|
$99.94B |
|
$31.62B |
|
$21.67B |
|
$29.87B |
|
$61.49B |
|
$38.45B |
|
$-13.99B |
|
$38.45B |
|
1.96B |
|
| Cash Flow Statement Financials | |
$3.65B |
|
$330.00M |
|
$-8.55B |
|
$11.46B |
|
$7.07B |
|
$-4.39B |
|
$262.00M |
|
$-5.33B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.79 |
|
-- |
|
-- |
|
0.36 |
|
0.77 |
|
76.31% |
|
34.24% |
|
34.24% |
|
-- |
|
32.36% |
|
26.48% |
|
$3.40B |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.55 |
|
1.56 |
|
57.65 |
|
9.39% |
|
-25.80% |
|
3.61% |
|
6.00% |
|
$19.63 |
|
$1.72 |
|
$1.84 |
|